Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc (RANI) Option Chain
As of September 18, 2026, Rani Therapeutics Holdings Inc is trading at $0.85, a -1.98% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 9,360.6%. IV Rank is 100%.
Read more
Tracking the RANI option chain helps you see every strike and expiry on Rani Therapeutics Holdings Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Rani Therapeutics Holdings Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RANI options activity at a glance. Use our scanner to monitor the RANI option chain in real time and filter for the RANI options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RANI stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the RANI option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where RANI stock options are being actively traded and where they are not.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes.
The company was incorporated in 2012 and is headquartered in San Jose, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Rani Therapeutics Holdings Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen RANI options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of RANI stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile99.60% Elevated
- Market cap (M$)120
- 52 weeks high-77.78%
- 52 weeks low91.11%
- Analyst recommendationStrong Buy
1.00 - Target price$7.20
752.07% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-0.27
- EPS growth next 5 years28.43%
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 100.00 | 109 | 0 | 0.40 | 0.35 | — | 0.75 | 0.50 | -41.86 | — | 0.05 | 0.00 | 0.05 | 0 | 130 | 0.00 |
| 100.00 | 1,570 | 0 | 0.08 | 0.00 | 0.05 | 0.10 | 1.00 | +16.28 | — | 0.75 | 0.15 | 0.60 | 0 | 0 | 0.00 |
| 100.00 | 533 | 0 | 0.10 | 0.00 | — | 0.10 | 1.50 | +74.42 | 0.30 | 1.20 | 0.65 | 0.10 | 0 | 3 | 0.00 |
| 100.00 | 21 | 0 | 0.75 | 0.00 | — | 0.75 | 2.00 | +132.56 | 0.80 | 1.70 | 1.15 | 0.10 | 0 | 30 | 0.00 |
| 100.00 | 216 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +190.70 | 1.30 | 2.20 | 1.65 | 0.10 | 0 | 0 | 0.00 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full RANI option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→